Zobrazeno 1 - 10
of 721
pro vyhledávání: '"F Crisafulli"'
Autor:
M. Filippini, G. Fontana, P. Bizioli, F. Crisafulli, R. Orabona, S. Zatti, F. Franceschini, A. Tincani
Publikováno v:
Reumatismo, Vol 76, Iss 3 (2024)
Objective. This review aims to summarize the most recent and updated data on pregnancy in patients with axial spondyloarthritis (axSpA), focusing on the recurrence of pregnancy-related complications, the disease activity throughout gestation and the
Externí odkaz:
https://doaj.org/article/f41f6e6f6e834a3abb76734a926b16e2
Autor:
L Andreoli, G Moroni, L Iaccarino, D Roccatello, M Larosa, F Crisafulli, M Radin, I Cecchi, E Klumb, G De Jesùs, MA Saavedra, GV Reyes-Navarro, F Tamborini, C Chighizola, S Sciascia
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/b998b2cf425e49b78568f44eca4c0c45
Autor:
Aria Gastón-Panthaki, Ana Serrano, Narmin Virani, Jane Sylvestre, Betsy F. Crisafulli, Carolyn B. Becker
Publikováno v:
Body Image. 45:46-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::683ec3668727c16a06e677f298d6488d
https://doi.org/10.1016/j.bodyim.2023.01.009
https://doi.org/10.1016/j.bodyim.2023.01.009
Autor:
M Radin, F Crisafulli, I Cecchi, E Klumb, G De Jesùs, MA Saavedra, GV Reyes-Navarro, L Iaccarino, M Larosa, G Moroni, F Tamborini, D Roccatello, L Andreoli, C Chighizola, S Sciascia
Publikováno v:
Friday 07 October 2022 from 13:00 to 14:10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82c44c9d53cefd46f4d93ee80873bee4
https://doi.org/10.1136/lupus-2022-elm2022.196
https://doi.org/10.1136/lupus-2022-elm2022.196
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. Gurnari, M.R. Pascale, A. Vitale, E. Diral, E. Galossi, G. Falconi, A. Bruno, F. Crisafulli, M. Frassi, C. Cattaneo, D. Bertoli, M. Bernardi, A. Condorelli, E. Morsia, E. Crisà, P. Triggianese, L. Brussino, G. Battipaglia, S. Bindoli, P. Sfriso, F. Caroni, A. Olivieri, S. Kordasti, F. Albano, F. Pane, P. Musto, M. Bocchia, E. Lugli, A. Rambaldi, R. Greco, F. Franceschini, F. Ciceri, L. Cantarini, M.T. Voso
Publikováno v:
Leukemia Research. 128:107148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c84e77492e981c83d825b4c496d0e050
https://doi.org/10.1016/j.leukres.2023.107148
https://doi.org/10.1016/j.leukres.2023.107148
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Radin, F. Crisafulli, I. Cecchi, E. Klumb, G. De Jesùs, M. A. Saavedra, G. V. Reyes-Navarro, L. Iaccarino, M. Larosa, G. Moroni, F. Tamborini, D. Roccatello, L. Andreoli, C. Chighizola, S. Sciascia
Publikováno v:
Annals of the Rheumatic Diseases. 81:1.1-2
BackgroundThe complement system is a key-player in the pathogenesis of systemic lupus erythematosus (SLE); its decreases correlate with disease activity and precedes flare. Since synthesis of complement proteins increase during gestational course, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6132540188a2ef30171095faad36bbf1
https://doi.org/10.1136/annrheumdis-2022-eular.2631
https://doi.org/10.1136/annrheumdis-2022-eular.2631
Publikováno v:
Annals of the Rheumatic Diseases. 81:1584.1-1584
BackgroundApremilast (APR) is an oral PDE4 inhibitor approved for the treatment of Psoriatic Arthritis (PsA). Its effectiveness has been assessed in clinical trials1,2, but real-life data are still scarce.ObjectivesTo evaluate the retention rate (RR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::102e99306dd742b7d7e57478cc617029
https://doi.org/10.1136/annrheumdis-2022-eular.3528
https://doi.org/10.1136/annrheumdis-2022-eular.3528
Autor:
D. Lini, C. Nalli, L. Andreoli, F. Crisafulli, M. Fredi, M. G. Lazzaroni, V. Bitsadze, A. Calligaro, V. Canti, R. Caporali, F. Carubbi, C. Chighizola, P. Conigliaro, F. Conti, C. De Carolis, T. Del Ross, M. Favaro, M. Gerosa, A. Iuliano, J. Khizroeva, A. Makatsariya, P. L. Meroni, M. Mosca, M. Padovan, R. Perricone, P. Rovere-Querini, G. D. Sebastiani, C. Tani, M. Tonello, S. Truglia, D. Zucchi, F. Franceschini, A. Tincani
Publikováno v:
Annals of the Rheumatic Diseases. 81:643-643
BackgroundAntiphospholipid Syndrome (APS) is a rare autoimmune disease characterized by thrombotic events and/or pregnancy morbidities in the presence of confirmed positivity for antiphospholipid antibodies (aPL). Complement was demonstrated to be in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26db3b265b08c1a164738d2352ec0289
https://doi.org/10.1136/annrheumdis-2022-eular.3524
https://doi.org/10.1136/annrheumdis-2022-eular.3524